Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cipla
Chinese Patent Office
QuintilesIMS
Mallinckrodt
Covington
Johnson and Johnson
Queensland Health
McKinsey

Generated: November 21, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Fosbretabulin

« Back to Dashboard

US Patents for Fosbretabulin

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fosbretabulin ➤ Try a Free Trial Combretastatin A-4 prodrug Arizona Board of Regents acting on behalf of Arizona State University (Tempe, AZ) ➤ Try a Free Trial
Fosbretabulin ➤ Try a Free Trial Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin A The University of Pittsburgh (Pittsburgh, PA) ➤ Try a Free Trial
Fosbretabulin ➤ Try a Free Trial Tubulin binding ligands and corresponding prodrug constructs Baylor University (Waco, TX) ➤ Try a Free Trial
Fosbretabulin ➤ Try a Free Trial Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di- amino acid salts, and mono- and di-amino acid ester salts Bristol-Myers Squibb Company (Princeton, NJ) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Fosbretabulin

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Fosbretabulin Australia 2293102 2020-07-19 ➤ Try a Free Trial
Fosbretabulin World Intellectual Property Organization (WIPO) 0206267 2020-07-19 ➤ Try a Free Trial
Fosbretabulin Austria 368046 2020-03-10 ➤ Try a Free Trial
Fosbretabulin Australia 2001243527 2019-02-18 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Mallinckrodt
Johnson and Johnson
Dow
Healthtrust
Citi
Harvard Business School
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: